In agreement with the results from human metastatic melanoma lines, EGCG treatment reversed the IFN-γ-induced PD-L1 upregulation at both protein (Figure 3A) and mRNA (Figure 3B) levels. This evidence concerns the gene IFNG and metastatic melanoma.